AUTL
Autolus Therapeutics Plc
NASDAQ · Healthcare · Biotechnology · GB
$1.94
+1.04%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.20
- Revenue estimate
- $40.0M
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.15
- EPS estimate
- -$0.21
- Revenue actual
- $45.7M
- Revenue estimate
- $38.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -6.4%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.21 | -$0.15 | Beat 28.57% | $45.7M |
| May 14, 2026 | -$0.29 | -$0.27 | Beat 6.90% | $26.2M |
| Mar 27, 2026 | -$0.26 | -$0.34 | Miss -30.80% | $24.3M |
| Nov 12, 2025 | -$0.23 | -$0.30 | Miss -30.43% | $21.2M |
| Aug 12, 2025 | -$0.24 | -$0.18 | Beat 25.00% | $20.9M |
| May 8, 2025 | -$0.24 | -$0.26 | Miss -8.33% | $9.0M |
| Mar 20, 2025 | -$0.21 | -$0.09 | Beat 57.14% | — |
| Aug 8, 2024 | -$0.19 | -$0.22 | Miss -15.79% | — |
| May 17, 2024 | -$0.10 | -$0.24 | Miss -140.00% | $10.1M |
| Mar 14, 2024 | -$0.26 | -$0.44 | Miss -69.23% | $1.8M |
| Nov 2, 2023 | -$0.24 | -$0.26 | Miss -8.33% | $406.0K |
| Aug 3, 2023 | -$0.22 | -$0.26 | Miss -18.18% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026